Conmed (CNMD) announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new independent chair of its board of Directors, effective May 21.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNMD:
- Conmed Corporation’s Earnings Call: Mixed Results Amid Growth and Challenges
- Conmed price target lowered to $61 from $91 at Needham
- Conmed’s Strong Q1 Performance and Raised Guidance Justify Buy Rating Despite Tariff Challenges
- Conmed price target lowered to $57 from $70 at Wells Fargo
- CONMED Corporation Reports Q1 2025 Financial Results